Stock-Based Compensation for Bio-Techne (TECH)
Stock-Based Compensation for Bio-Techne (TECH): headline value $41.58M · YoY +7.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingStock-Based CompensationSwitch metric
Latest period
$41.58M
YoY change
+7.3%
5Y CAGR
+4.8%
Peak year (2021)
$48.98M
Latest annual
$40.83M
Stock-Based Compensation history chart for Bio-Techne (TECH) from 1990 to 2025
Stock-Based Compensation history table for Bio-Techne (TECH) from 1990 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $40.83M | +7.3% | ||
| 2024 | $38.04M | -3.0% | ||
| 2023 | $39.23M | -7.0% | ||
| 2022 | $42.18M | -13.9% | ||
| 2021 | $48.98M | +51.3% | ||
| 2020 | $32.37M | +0.3% | ||
| 2019 | $32.28M | +14.3% | ||
| 2018 | $28.24M | +93.0% | ||
| 2017 | $14.63M | +55.2% | ||
| 2016 | $9.43M | +58.3% | ||
| 2015 | $5.96M | +69.1% | ||
| 2014 | $3.52M | +89.0% | ||
| 2013 | $1.86M | +13.6% | ||
| 2012 | $1.64M | +44.2% | ||
| 2011 | $1.14M | +0.3% | ||
| 2010 | $1.14M | -23.2% | ||
| 2009 | $1.48M | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — |
Stock-Based Compensation values are taken from Bio-Techne's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual stock-based compensation for Bio-Techne (TECH) came in at $40.83M – grew 7.3% year-over-year.
Across 2020–2025 (5 years), Bio-Techne stock-based compensation produced a CAGR of +4.8% – with the latest reading among the more recent periods of the dataset.
2021 marks the peak stock-based compensation at $48.98M, with the historical low of $0 recorded in 1990.
Within Healthcare, Bio-Techne (TECH) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
Bio-Techne Stock-Based Compensation by Year
Bio-Techne Stock-Based Compensation 2025: $40.83M
Bio-Techne stock-based compensation in 2025 was $40.83M, grew 7.3% from 2024.
Bio-Techne Stock-Based Compensation 2024: $38.04M
Bio-Techne stock-based compensation in 2024 was $38.04M, edged down 3.0% below 2023.
Bio-Techne Stock-Based Compensation 2023: $39.23M
Bio-Techne stock-based compensation in 2023 was $39.23M, declined 7.0% below 2022.
Bio-Techne Stock-Based Compensation 2022: $42.18M
Bio-Techne stock-based compensation in 2022 was $42.18M, declined 13.9% below 2021.
Bio-Techne Stock-Based Compensation 2021: $48.98M
Bio-Techne stock-based compensation in 2021 was $48.98M.
See more financial history for Bio-Techne (TECH).
Sector peers — Stock-Based Compensation
Companies in the same sector as Bio-Techne, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Bio-Techne's stock-based compensation?
Latest reported stock-based compensation for Bio-Techne (TECH) is $41.58M (period ending December 31, 2025).
How has Bio-Techne stock-based compensation changed year-over-year?
Bio-Techne (TECH) stock-based compensation changed +7.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne stock-based compensation?
Bio-Techne (TECH) stock-based compensation compound annual growth rate is +4.8% over the most recent 5 years available.
When did Bio-Techne stock-based compensation hit its highest annual value?
Bio-Techne stock-based compensation reached its highest annual value of $48.98M in 2021.
What was Bio-Techne stock-based compensation in 2024?
Bio-Techne (TECH) stock-based compensation in 2024 was $38.04M.
What was Bio-Techne stock-based compensation in 2025?
Bio-Techne (TECH) stock-based compensation in 2025 was $40.83M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.